KKI-5
KKI-5 is a specific inhibitor of tissue kallikrein. KKI-5 can attenuate breast cancer cell invasion[1].
Product Specifications
CAS Number
97145-43-2
UNSPSC
12352209
Hazard Statement
H302-H315-H319
Target
Kallikrein
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Kallikrein_Inhibitor.html
Solubility
H2O
Smiles
NC(CC[C@@H](C(N)=O)NC([C@H](C(C)C)NC([C@H](CO)NC([C@H](CCCNC(N)=N)NC([C@H](CC1=CC=CC=C1)NC([C@H]2N(CCC2)C(C)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C35H55N11O9
Molecular Weight
773.88
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Deshpande MS, et al. Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392. J Med Chem. 1992 Aug 21;35 (17) :3094-102.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1319228-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus Protein vraX (vraX)
Sign In for Pricing
View Details MBS1319228-02 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus Protein vraX (vraX)
Sign In for Pricing
View Details MBS1319228-03 0.02 mg (Yeast)
Recombinant Staphylococcus aureus Protein vraX (vraX)
Sign In for Pricing
View Details MBS1319228-04 0.1 mg (Yeast)
Recombinant Staphylococcus aureus Protein vraX (vraX)
Sign In for Pricing
View Details MBS1319228-05 0.02 mg (Baculovirus)
Recombinant Staphylococcus aureus Protein vraX (vraX)
Sign In for Pricing
View Details